Status:
RECRUITING
Accuracy of Cardiac Arrhythmias and Conduction Disorders Diagnosis Using a Smartwatch
Lead Sponsor:
Federal University of Piaui
Conditions:
Cardiovascular Diseases
Cardiac Arrhythmia
Eligibility:
All Genders
18+ years
Brief Summary
Implantable devices increase the detection of silent atrial fibrillation in high-risk populations, being a useful tool in the early diagnosis of these patients, allowing monitoring for a longer time. ...
Detailed Description
The main objective of this study is to analyze, in patients with cardiovascular disease, the electrocardiographic aspects detected from the smartwatch device in comparison to the conventional electroc...
Eligibility Criteria
Inclusion
- Age ≥ 18 years;
- Presence of one or more of the following diagnoses: systemic arterial hypertension, heart failure, valve disease, coronary atherosclerotic disease, myocardial infarction, endocarditis, myocarditis, diabetes, cardiac arrhythmias and patients with cardiac pacemakers or implantable automatic defibrillators.
Exclusion
- Patients who have electrocardiographic tracings, whether obtained from the watch or the conventional method, of poor quality that make it impossible or that makes the diagnosis difficult due to the technical aspect of the performance.
- Withdrawal of the consent form at the request of the patient or guardian.
Key Trial Info
Start Date :
June 7 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2025
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT04437914
Start Date
June 7 2021
End Date
June 30 2025
Last Update
September 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Carlos Eduardo B. de Lima
Teresina, Piauí, Brazil, 64048-350